IMMB OTC
Immunotech Laboratories, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +100.0%
1Y: +100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$31K
+0.0% ▲
Capital Expenditures
$4
+0.0% ▲
5Y CAGR: -82.9%
Free Cash Flow
-$31K
+0.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$0
+0.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2003 | FY2004 | FY2005 | FY2013 | FY2016 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$315K | -$111K | -$34M | -$626K | -$493K |
| Depreciation & Amort. | $2K | $0 | $0 | $14K | $16K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $542K | $86K | $146K | $314K | $462K |
| Other Non-Cash Items | -$285K | $0 | $33M | -$14K | -$16K |
| Operating Cash Flow | -$55K | -$25K | -$283K | -$312K | -$31K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | -$11K | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $14K | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $16K |
| Investing Cash Flow | $0 | $0 | $0 | $3K | $16K |
| — Financing Activities — | |||||
| Net Debt Issuance | $59K | $0 | $0 | $0 | $11K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$8K | $20K | $330K | $249K | $0 |
| Financing Cash Flow | $51K | $20K | $330K | $309K | $24K |
| Net Change in Cash | -$4K | -$5K | $47K | $0 | $0 |
| Cash End of Period | $5K | $259 | $47K | $633 | $14K |
| Free Cash Flow | -$55K | -$25K | -$283K | -$323K | -$31K |